October 17, 2011
Mitsubishi Tanabe Pharma Corporation (MTPC) announced on October 14 that it has concluded an exclusive development and marketing agreement with Toray Industries Inc. for the novel pruritus treatment developed by Toray TRK-820 (Toray’s development code; generic name: nalfurafine HCl) in...read more